Business Segments · Sales
Biotechnology — Sales
Danaher Biotechnology — Sales increased by 13.1% to $2.03B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $1.87B to $2.03B. Over 4 years (FY 2021 to FY 2025), Biotechnology — Sales shows a downward trend with a -4.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or demand, while a decrease suggests competitive pressure or market contraction.
Detailed definition
Represents the total revenue generated from the sale of products and services within the biotechnology business segment....
Peer comparison
Standard revenue reporting across life science and diagnostic peers.
Metric ID:
dhr_segment_biotechnology_salesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.14B | $2.14B | $2.14B | $2.22B | $2.27B | $2.05B | $2.22B | $1.86B | $1.89B | $1.66B | $1.76B | $1.52B | $1.71B | $1.65B | $1.87B | $1.61B | $1.85B | $1.80B | $2.03B |
| QoQ Change | — | +0.0% | +0.0% | +3.4% | +2.3% | -9.4% | +8.3% | -16.1% | +1.1% | -11.7% | +5.7% | -13.4% | +12.4% | -3.5% | +13.1% | -13.8% | +14.8% | -2.8% | +13.1% |
| YoY Change | — | — | — | — | +5.8% | -4.2% | +3.8% | -15.9% | -16.8% | -18.9% | -20.9% | -18.2% | -9.1% | -0.7% | +6.3% | +5.8% | +8.0% | +8.8% | +8.8% |
Range$1.52B – $2.27B
CAGR-1.2%
Avg YoY Growth-3.8%
Median YoY Growth-0.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — sales?
- Danaher (DHR) reported biotechnology — sales of $2.03B in Q4 2025.
- How has Danaher's biotechnology — sales changed year-over-year?
- Danaher's biotechnology — sales increased by 8.8% year-over-year, from $1.87B to $2.03B.
- What is the long-term trend for Danaher's biotechnology — sales?
- Over 4 years (2021 to 2025), Danaher's biotechnology — sales has grown at a -4.0% compound annual growth rate (CAGR), from $8.57B to $7.29B.
- What does biotechnology — sales mean?
- Total revenue generated by the biotechnology business segment.